RV-1729 is a phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) inhibitor potentially for the treatment of asthma. References: Norman P. Evaluation of WO2013136076: two crystalline forms of the phosphatidylinositol 3-kinase-δ inhibitor RV-1729. Expert Opin Ther Pat. 2014 Apr;24(4):471-5. doi: 10.1517/13543776.2014.865725. Epub 2013 Nov 27. PubMed PMID: 24283201.

纯度：≥98%

CAS：1293915-42-0